In Patients With Thyroid Disease, GLP-1 RAs May Convey a Protective Benefit Against TED
- Posted on: Jul 17 2026
- Leave a response
A retrospective, population-based, matched cohort study evaluated the risk of thyroid eye disease (TED) with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Source: AAO
Posted in: Uncategorized
